Global Chemotherapy Chairs Market, By Chair Type (Electric, Hydraulic, and Manual), By Demographics (Pediatric Population and Adult Population), By End User (Hospitals and Specialty Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 503.5 million in 2018, and is projected to exhibit a CAGR of 5.9% over the forecast period (2019 - 2026), as highlighted in a new report published by Coherent Market Insights.
Increasing technological developments, donations for chemotherapy chairs to provide better experience to patients during chemotherapy are major factors expected to drive growth of the global chemotherapy chairs market. Various organizations are focusing on developing more comfortable, functional, and ergonomic chemotherapy chairs, which are customized as per the patient’s need. This is expected to boost the global chemotherapy chair market size.
For instance, Mankato Clinic installed 12 new infusion chairs, called Medcor infusion chairs in its infusion center in June 2018. Many patients feel cold from treatments and find it difficult to sit throughout the day. The new chairs have heat and massage features to help patients feel more relaxed and comfortable. Manufacturers in the global chemotherapy chairs market are focusing on manufacturing multipurpose chairs, in order to gain significant market share.
For instance, Champion Manufacturing, Inc.’s product Elevate Multi-Purpose Chair is an infusion chair with Trendelenburg foot switches on both sides of underframe. It has rechargeable battery back-up, motorized vertical height adjustment, central locking brake system, articulating armrest for ease of patient transfer, and with an adjustable head pillow.